Best Blood Advances Talks Podcasts (2024)

1
Episode 48. Management of Polycythemia Vera with Dr. Aaron Gerds 57:09

1h ago57:09

57:09

In this episode, we discussed the diagnosis and management of polycythemia vera with Dr. Aaron T. Gerds. Here are the shownotes with the key studies discussed: 1. MIPS PV scoring system https://pubmed.ncbi.nlm.nih.gov/31945802/ 2. REVEAL study https://ashpublications.org/blood/article/143/16/1646/506717/Association-between-elevated-white-blood-cell…

1
S5 Ep12: Advancing Melanoma Treatment: Hamid on Lifileucel's Role 18:04

9h ago18:04

18:04

In this episode of Targeted Talks, Omid Hamid, MD, discusses data supporting the use of lifileucel for the treatment of advanced melanoma.By Targeted Talks

1
Episode 47. ASCO/EHA 2024 Lymphoma Updates with Dr. Gloria Iacoboni 47:48

7d ago47:48

47:48

In this episode, we reviewed the hottest updates in lymphoma from ASCO and EHA 2024, held in Chicago and Madrid respectively, with Dr. Gloria Iacoboni, a haematologist from University Hospital Vall d'Hebron, in Barcelona, Spain. Here are the key abstracts we discussed: 1. STARGLO: Glofit-GEMOX vs R-GEMOX in relapsed/refractory DLBCL https://library…

1
S5 Ep11: Transforming Prostate Cancer Care Through Personalized Medicine 23:58

12d ago23:58

23:58

Adam Weiner, MD, discusses his journey toward becoming an oncologist with a focus in urology in this episode of Emerging Experts.By Targeted Talks

1
Episode 75: What was the client thinking? That was not really what I meant! 4:49

22d ago4:49

4:49

Welcome back to another episode of Better Work Stories by The Vet Podcast. I'm veterinarian, Dr. Bryan Gregor. Now, relaying bad blood results to clients can sometimes be difficult and stressful for veterinarians. But this [00:01:00] discussion with a client just takes the cake. Can you imagine, or more likely not imagine, What was going on inside …

1
S5 Ep10: Dhakal Reflects on the FDA Approval of Cilta-Cel for Earlier Lines of RRMM 20:11

1M ago20:11

20:11

In this episode of Targeted Talks, Binod Dhakal, MD, MS, discusses the recent FDA approval of ciltacabtagene autoleucel for the treatment of relapsed/refractory multiple myeloma.By Targeted Talks

1
Episode 46. Updates in Myeloma MRD with Dr. Ben Derman and Dr. Manni Mohyuddin 57:48

1M ago57:48

57:48

In this episode, we dive into updates in Minimal Residual Disease (MRD) in multiple myeloma, along with the FDA ODAC meeting in April 2024 to decide on MRD as a surrogate endpoint for accelerated approval. Our guests are Dr. Benjamin Derman and Dr. Manni Mohyuddin. Here are the key papers we discussed: 1. Recording of FDA ODAC meeting: https://www.…

1
Episode 45. Updates in Primary Myelofibrosis with Dr. Ayalew Tefferi 1:00:53

2M ago1:00:53

1:00:53

In this episode, we discuss updates in primary myelofibrosis with Dr. Ayalew Tefferi from the Mayo Clinic. The key studies and trials discussed are as follows: · GIPSS: Genetically inspired prognostic scoring system that is exclusively based on genetic markers. § https://www.nature.com/articles/s41375-018-0107-z · MIPSS70+ Version 2.0: Mutation and…

1
Episode 74: Can I have a lift? - Better Veterinary Work Stories 7:01

2M ago7:01

7:01

After almost a year off (for reasons you will find out in the podcast!) I am back. I am Dr Bryan Gregor, a veterinarian from New Zealand. During my long life as a veterinarian, I have seen a lot of weird, quirky funny and just down right bizarre stuff! This is just one of them. Follow me on social media @vetpodcast and as they say, like and subscri…

1
S5 Ep9: Unlocking the Potential of Technology in Community Oncology 25:49

2M ago25:49

25:49

In this episode of Targeted Talks, Nini Wu, MD, MBA, chief medical and development officer at Cardinal Health, shares her insights on the ever-changing world of technology in the community oncology setting.By Targeted Talks

1
Episode 44. Maintenance Therapy in Multiple Myeloma with Dr. Hira Mian and Dr. Manni Mohyuddin 52:58

2M ago52:58

52:58

In this episode, we dive into the data on maintenance therapy in multiple myeloma with Dr. Hira Mian and Dr. Manni Mohyuddin. Here are the key studies we discussed: 1. Meta-analysis of individual patient-level data from CALGB, IFM, and Italian maintenance RCTs (lenalidomide vs placebo or observation): https://pubmed.ncbi.nlm.nih.gov/28742454/ 2. My…

1
S5 Ep8: LaPelusa’s Journey in the Dynamic Field of GI Oncology 14:20

3M ago14:20

14:20

In the latest episode of Emerging Experts, Michael LaPelusa, MD, hematology and oncology fellow at MD Anderson Cancer Center, shares his insights, experiences, and passion for cancer research, particularly in the realm of gastrointestinal cancers.By Targeted Talks

1
Episode 43. Essential Thrombocythemia with Dr. Raajit Rampal 35:28

3M ago35:28

35:28

In this episode, we discuss the diagnosis and management of Essential Thrombocythemia with Dr. Raajit Rampal. Here are the shownotes: 1. IPSET (revised) system, risk categories are defined by the presence of a prior thrombosis, age, and JAK2 mutation status: · Very low risk: No prior thrombosis, age ≤60 years, JAK2-unmutated · Low risk: No prior th…

1
S5 Ep7: The Future of Breast Cancer Care: Blackwood on Personalized Approaches 26:53

3M ago26:53

26:53

In this episode of Targeted Talks, M. Michele Blackwood, MD, FACS, director of breast surgery, Robert Wood Johnson (RWJ), Barnabas Health, director of women’s oncologic health, RWJ Barnabas Health and Rutgers Cancer Institute, and head of breast surgery, Cooperman Barnabas Medical Center, discusses the current landscape of breast cancer treatment a…

1
S5 Ep6: Dizman’s Global Pursuit to Cancer Research and Understanding 19:05

4M ago19:05

19:05

In this episode of Emerging Experts, Nazli Dizman, MD, shares the intricacies of her journey towards becoming an oncologist in the United States.By Targeted Talks

1
Episode 42. CAR T-cell Therapy in Early Relapsed Myeloma with Dr. Samer Al Hadidi 54:49

4M ago54:49

54:49

In this episode, we talked about overall survival data from CARTITUDE-4 and KarMMa-3 that was presented at FDA ODAC meeting with Dr. Samer Al Hadidi from University of Arkansas Myeloma Center. RCTs of BCMA CAR T-cell Therapy in Early Relapsed Multiple Myeloma: a) KarMMa-3 (ide-cel): https://pubmed.ncbi.nlm.nih.gov/36762851/ b) CARTITUDE-4 (cilta-ce…

1
S5 Ep5: FDA Approval Marks Amivantamab's Milestone in EGFR+ NSCLC 22:32

4M ago22:32

22:32

In this episode, Joshua K. Sabari, MD, discusses the FDA approval of amivantamab plus chemotherapy as a first-line treatment for patients with EGFR exon 20 insertion mutation-positive non-small cell lung cancer.By Targeted Talks

1
Episode 41. Career Development as a Clinician-Investigator with Dr. Ayalew Tefferi 47:22

4M ago47:22

47:22

In this episode, we discuss mentorship and career development as a clinician-investigator with Dr. Ayalew Tefferi from the Mayo Clinic.By Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff

1
S5 Ep4: Enhancing Precision in Immunotherapy: CD8 PET-Avidity in RCC 19:03

5M ago19:03

19:03

In this episode of Emerging Experts, Peter Zang, MD, highlights research on baseline CD8 lymph node avidity with 89-Zr-crefmirlimab for the treatment of patients with metastatic renal cell carcinoma and response to immunotherapy.By Targeted Talks

1
Episode 40. Management of Newly Diagnosed AL Amyloidosis with Dr. Angela Dispenzieri 52:34

5M ago52:34

52:34

In this episode we discuss the management of newly diagnosed AL amyloidosis with Dr. Angela Dispenzieri from the Mayo Clinic. Here are the key articles discussed: 1. Optimal use of tissue biopsy in AL amyloidosis: https://pubmed.ncbi.nlm.nih.gov/28271734/ 2. Mayo 2004 staging: https://pubmed.ncbi.nlm.nih.gov/15365071/ 3. Mayo 2012 staging: https://…

1
S5 Ep3: Advancing Myeloma Treatment With Blood-Based MRD Testing 22:04

5M ago22:04

22:04

In season 5, episode 3 of Targeted Talks, Ben Derman, MD, assistant professor of medicine at the University of Chicago Medical Center, dissects the latest advancements in myeloma treatment, focusing on the role of ClonoSeq and minimal residual disease monitoring.By Targeted Talks

1
Episode 39. ASH 2023 Leukemia and Myeloid Neoplasm Recap with Dr. Anand Patel 55:14

6M ago55:14

55:14

In this episode, we discuss top abstracts in the myeloid space from the American Society of Hematology 2023 meeting with Dr. Anand Patel. Here are the abstracts that were discussed: 1. TRANSFORM-1: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, International Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitini…

1
S5 Ep2: Beyond the First-Line: Economides on Advancing Therapies in RCC 20:06

6M ago20:06

20:06

In our 4th episode of Emerging Experts, Minas P. Economides, MD, assistant professor of medicine at NYU Langone Perlmutter Cancer Center, unveils the challenges and opportunities for renal cell carcinoma treatment, focusing on the lack of therapies available in the second-line setting.By Targeted Talks

1
Episode 38. GVHD Prophylaxis in Allo-Transplant with Dr. Shernan Holtan 52:10

6M ago52:10

52:10

In this episode, we talk about GVHD prophylaxis, including recent data on post-transplant cyclophosphamide and abatacept with Dr. Shernan Holtan from the University of Minnesota. Here are the key trials we discussed: 1. BMT CTN 1203 trial: Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate,…

1
S5 Ep1: A Deep Dive Into the Evolving Landscape of Prostate Cancer 23:52

6M ago23:52

23:52

In season 5, episode 1 of Targeted Talks, Badrinath Konety, MD, president of the Allina Health Cancer Institute and the chief academic officer for Allina Health, delves into the critical topic of prostate cancer screening, particularly for men within a community setting, and discusses some of the recent advancements in the prostate cancer space.…

1
Episode 37. ASH 2023 Myeloma Recap with Dr. Ben Derman 1:01:40

7M ago1:01:40

1:01:40

In this episode, we discuss the key abstracts in myeloma and related plasma cell disorders at ASH23 with Dr. Benjamin Derman. Here are the abstracts discussed in this episode: First, we will focus on a few abstracts in precursor states, MGUS. 1. New diagnostic criteria for light chain MGUS (IStopMM): https://ash.confex.com/ash/2023/webprogram/Paper…

1
Why Should You Donate Blood? 5:58

7M ago5:58

5:58

In this episode, we will be talking about the importance of blood donation and the different blood donation types available such as whole blood, power red cell, platelet, plasma donation, etc. Although, a lot of people donate blood after disasters, it's important to keep in mind that blood is NEEDED almost EVERYDAY of the year! Everyday there's a p…

1
Episode 36. ASH 2023 Lymphoma Recap with Dr. Toby Eyre 50:59

7M ago50:59

50:59

In this episode, we review the hottest updates in lymphoma from the American Society of Hematology 2023 meeting with Dr Toby Eyre, a consultant haematologist at the University of Oxford in the UK. Here are the abstracts that were discussed: Mantle Cell Lymphoma 1. BOVen trial-A Multicenter Phase 2 Trial of Zanubrutinib, Obinutuzumab, and Venetoclax…

1
S4 Ep20: Lisberg Discusses Dato-DXd's Role in Advanced Lung Cancer Care 15:49

7M ago15:49

15:49

In season 4, episode 20 of Targeted Talks, Aaron Lisberg, MD, a thoracic medical oncologist at the University of California, Los Angeles, delves into findings from the phase 3 TROPION-Lung01 study of datopotamab deruxtecan for the treatment of patients with advanced or metastatic non–small cell lung cancer.…

1
S4 Ep19: Navigating the Landscape of Immunotherapy Toxicities 15:57

8M ago15:57

15:57

In our third episode of Emerging Experts, host Jordyn Sava is joined by Matthew Hadfield, DO, a third-year hematology/oncology fellow at Brown University, to discuss his interest and research in immunotherapy toxicities.By Targeted Talks

1
Episode 35. Bispecific Antibodies in Lymphoma with Dr. Michael Dickinson 1:08:40

8M ago1:08:40

1:08:40

In this episode, we delve into the weeds of bispecific antibodies across lymphomas with Dr. Michael Dickinson from Peter MacCallum Cancer Center, Melbourne, Australia. Here are the key articles we discussed: 1. Glofitamab for Relapsed/Refractory DLBCL: https://pubmed.ncbi.nlm.nih.gov/36507690/ 2. Long-term follow-up data on blinatumomab in relapsed…

1
Episode 34. Management of FLT3 AML with Dr. Alexander Perl 1:08:19

8M ago1:08:19

1:08:19

In this episode, we dive into the management of newly diagnosed and relapsed FLT3-positive AML with Dr. Alexander Perl. Here are the shownotes: 1. Assessment of minimal residual disease in standard-risk AML https://www.nejm.org/doi/full/10.1056/nejmoa1507471 2. RATIFY study: Midostaurin plus chemotherapy for AML with a FLT3 mutation https://www.nej…

1
S4 Ep18: Behind the FDA Approval of Fruquintinib for Previously Treated mCRC 9:24

8M ago9:24

9:24

In season 4, episode 18 of Targeted Talks, Arvind Dasari, MD, MS, dives into the recent approval of fruquintinib for patients with with metastatic colorectal cancer.By Targeted Talks

1
E90 - Mastering the Mindset of Empowerment: Annie Gibbins' Path to Freedom 1:20:52

9M ago1:20:52

1:20:52

Are you ready to unlock your true potential and live a life of empowerment and success? Do you crave the freedom to pursue your dreams and achieve fulfillment in both your personal and professional life? Join us as Annie Gibbins reveals the key to turning your aspirations into reality. She will share her proven solution, allowing you to attain the …

1
Episode 33. The art of caring for patients at the end of life with Dr. Azra Raza 59:15

9M ago59:15

59:15

In this episode, we discuss the art of caring for terminally ill patients with Dr. Azra Raza. We also discuss her book titled "The First Cell", where she recounts numerous poignant stories of her patients with terminal cancer, and teaches us how to find hope amidst despair. Link to the book: https://www.amazon.com/First-Cell-Human-Pursuing-Cancer/d…

1
S4 Ep17: Bridging Science and Compassion in Cancer Care 20:24

9M ago20:24

20:24

In this episode of Emerging Experts, host Jordyn Sava is joined by Hemali Batra-Sharma, MD, fellow, Hematology/Oncology, University of California San Diego (UCSD) Medical Center, UCSD Health, to discuss insights into her passion for oncology and some of the experiences that have helped to shape her career.…

1
Episode 32: t(11;14) Multiple Myeloma and Role of Venetoclax with Dr. Rafael Fonseca and Dr. Martin Kaiser 58:50

9M ago58:50

58:50

In this episode, we discuss the biology and management of t(11;14) multiple myeloma and the role of venetoclax with Dr. Rafael Fonseca and Dr. Martin Kaiser. Here are the shownotes: 1. Excellent tweetorial thread by Dr. Fonseca highlighting some of the historical studies that identified t(11;14) and its prognostic impact in myeloma: https://x.com/R…

1
S4 Ep16: Tailoring Treatments to Better Outcomes in Liver Cancer 25:35

10M ago25:35

25:35

In season 4, episode 16 of Targeted Talks, Susanne G. Warner, MD, hepatobiliary and pancreas surgeon at the Mayo Clinic in Rochester, Minnesota, discusses the importance of tailoring treatments for patients with liver cancer, taking into account the staging of the cancer.By Targeted Talks

1
Episode 31. Management of CNS Lymphoma 51:40

10M ago51:40

51:40

In this episode, we discuss the management of primary CNS lymphoma, secondary CNS lymphoma and CNS prophylaxis with Dr. Kate Cwynarski. Here are the shownotes: 1. ASH 2022 data on PET scan in CNS lymphoma - https://ashpublications.org/blood/article/140/Supplement%201/1334/492207/Is-It-Possible-to-Omit-Bone-Marrow-Biopsy-in?searchresult=1 2. Elizabe…

1
S4 Ep15: Desai on Embracing Curiosity and Change in the Oncology Field 11:50

10M ago11:50

11:50

In our first episode of Emerging Experts, Aakash Desai, MD, MPH, discusses his journey through the oncology field by reminiscing on the encouraging guidance of his mentors, personal research goals, and his experiences thus far as an oncologist.By Targeted Talks

1
S4 Ep14: First Real-World Data on Second-Generation AR Inhibitor Use in nmCRPC 7:52

10M ago7:52

7:52

Alicia Morgan, MD, MPH on real-world data from the DEAR study.By Targeted Talks

1
Episode 30. Management of High-Risk Myeloma 1:08:29

11M ago1:08:29

1:08:29

In this episode, we discuss with Dr. Martin Kaiser how to identify and manage newly diagnosed high-risk multiple myeloma in the current era of effective frontline therapies. Here are the key studies that we touched upon: 1. Phase II OPTIMUM (MUKnine) trial in ultra-high-risk myeloma and PCL: https://pubmed.ncbi.nlm.nih.gov/37315268/ 2. Meta-analysi…

1
S4 Ep13: Strategies for Neoadjuvant NSCLC Treatment 10:04

11M ago10:04

10:04

An interview with Benny Weskler, MBA, MD, FACS, FACCP of Allegheny Health Network.By Targeted Talks

1
Episode 29. Management of Peripheral T-Cell Lymphoma 56:13

11M ago56:13

56:13

In this episode, we discuss the diagnosis and management of peripheral T-cell lymphoma with Dr. Steven Horwitz, with a focus on the 3 most common types-Peripheral T-cell Lymphoma-NOS, Angioimmunoblastic T-cell Lymphoma (AITL), and Anaplastic Large Cell Lymphoma (ALCL). Here are the key papers we discussed: 1. “How I Treat Peripheral T-cell Lymphoma…

1
Episode 28. Management of CCUS 47:54

11M ago47:54

47:54

In this episode, we discuss the diagnosis and management/monitoring of Clonal Cytopenias of Unknown Significance (CCUS) with Dr. Uma Borate. We also discuss the emerging data on risk stratification and key trials in this space that are currently ongoing. Here are the shownotes: 1. CCUS and risk of transformation to myeloid neoplasms: https://www.sc…

1
S4 Ep12: Lessons from Real-World Cases of Small Cell Lung Cancer 16:53

12M ago16:53

16:53

Federico Albrecht, MD discusses 2 small cell lung cancer cases.By Targeted Talks

1
089 - Tap into Your Inner Power: Discover the Secrets of Qigong and Tai Chi with Lee Holden 55:21

12M ago55:21

55:21

In the halls of UC Berkeley, Lee Holden's life took an unexpected turn. A vibrant soccer player, he found himself at a crossroads after an agonizing injury. Modern medicine failed to heal his pain, pushing him to seek solace in a world of ancient secrets and mystical energy. Little did he know, this path would lead him to a remarkable transformatio…

1
S4 Ep11: Social Determinants of Health Impacting Oncology Today 10:16

12M ago10:16

10:16

By Targeted Talks

1
Episode 27. Management of PNH 1:03:29

12M ago1:03:29

1:03:29

In this episode, we delve into the diagnosis and management of Paroxysmal Nocturnal Hemoglobinuria (PNH) with Dr. Robert Brodsky. Here are the shownotes for key papers we discussed in the episode: How I treat PNH: https://pubmed.ncbi.nlm.nih.gov/33512400/ Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired sev…

1
Episode 26. Management of Newly Diagnosed Hodgkin's Lymphoma 57:26

1y ago57:26

57:26

In this episode, we delve into the history of frontline treatment in young/fit patients with Hodgkin's lymphoma and recent developments in the past decade with Dr. Nancy Bartlett from Washington University. Link for our Blood Cancer Talks Survey: https://bit.ly/BCTS Here are the key trials we discussed: 1. RATHL Trial (PET-adapted treatment of Adva…

Podcasts Worth a Listen

Blood Advances Talks Podcasts

Podcasts Worth a Listen

Quick Reference Guide